FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3287411000001108: Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17594701000001110 Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17594801000001118 Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Is a Aminophylline hydrate 225mg modified-release tablet false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Xanthine false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Smooth muscle relaxant false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Aminophylline true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Is a Aminophylline hydrate 225mg modified-release tablets true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Is a Phyllocontin Continus true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has specific active ingredient Aminophylline hydrate true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of False Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start